Radiolabelled rhTSH for the diagnosis of metastases in differentiated thyroid cancer

Radiolabelled rhTSH for the diagnosis of metastases in differentiated thyroid cancer

Detaylı Bibliyografya
Asıl Yazarlar:	Corsetti, F, Chianelli, M, Cornelissen, B, Van de Wiele, C, D'Alessandria, C, Slegers, G, Mather, S, Scopinaro, F, Di Mario, U, Filetti, S, Signore, A
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection.
Yazar:: Corsetti, F, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

I-123-labelled interleukin-12, a new radiopharmaceutical for imaging Th1-mediated chronic inflammation: In vitro and animal studies
Yazar:: Annovazzi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Synthesis of Tc-99m-Hynic-interleukin-12, a new radiopharmaceutical for imaging Th-1-lymphocytes
Yazar:: Annovazzi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes.
Yazar:: Annovazzi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

ANTIBODIES AGAINST THYROID AND THYROID STIMULATING HORMONE (TSH): WHO’S WHO?
Yazar:: Adina Ghemigian, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Obesity is associated with increased serum TSH level, independent of thyroid function
Yazar:: M Bastemir, ve diğerleri
Baskı/Yayın Bilgisi: (2007-07-01)

99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.
Yazar:: Chianelli, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Clinical Implications of Different Thyroid-Stimulating Hormone (TSH) Reference Intervals between TSH Kits for the Management of Subclinical Hypothyroidism
Yazar:: Won Sang Yoo
Baskı/Yayın Bilgisi: (2024-02-01)

TSH-Secreting Pituitary Macroadenoma in a Girl with Lingual Thyroid
Yazar:: S. Wacharasindhu, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Analysis of Hematological Parameters According to TSH Levels in Thyroid Patients
Yazar:: Taner Demirci, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
Yazar:: Cornelissen, B, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Microscale radiolabelling of antibodies with zirconium-89 for positron emission tomography
Yazar:: Knight, J, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
Yazar:: Hsi-Chen Tsai, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

The interference of anti-TSH autoantibody on clinical TSH detection
Yazar:: Mulin Tang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Scaling-down antibody radiolabeling reactions with zirconium-89
Yazar:: Knight, JC, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)
Yazar:: Michela Varani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Methods for Radiolabelling Nanoparticles: PET Use (Part 2)
Yazar:: Valeria Bentivoglio, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use
Yazar:: Valeria Bentivoglio, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Yazar:: Alexander Wurzer, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
Yazar:: Kersemans, V, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Design of a self-contained fixed offshore oil production platform for the shores of Venezuela.
Yazar:: D'Alessandria, Luis Felipe
Baskı/Yayın Bilgisi: (2005)

Quantitative Assessment Of The Variations In Thyroid Dimensions In Relation To Increase In Serum TSH In Euthyroids
Yazar:: Mahrukh Kamran, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Pediatric TSH Reference Intervals and Prevalence of High Thyroid Antibodies in the Lebanese Population
Yazar:: Marie-Hélène Gannagé-Yared, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

The Relationship of Clinicopathological Factors of the Tumor with Preoperative TSH Level in Papillary Thyroid Cancers
Yazar:: Evren Besler, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

TSH enhances neurite outgrowth
Yazar:: Maryam Mansoori, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

A meta-analysis of the value of serum TSH concentration in the diagnosis of differentiated thyroid cancer in patients with thyroid nodules
Yazar:: Xiao-Yu Fan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis
Yazar:: Krzysztof Kaliszewski, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
Yazar:: Cornelissen, B, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Iodine nutritional status and its associations with thyroid function of pregnant women and neonatal TSH
Yazar:: Lijun Fan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Pre-operative serum TSH level estimation for predicting malignant nodular thyroid disease
Yazar:: Kotaiba Kh. Hamdi, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

Influence of fasting prior to 18F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake
Yazar:: Sonia Grigorascu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
Yazar:: Cornelissen, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial
Yazar:: Kristina Hasselgren, MD, PhD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Gender, FT4 levels, T stage, and BMI as predictors of TSH levels in thyroid cancer patients
Yazar:: Sen Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of Graves’ disease
Yazar:: Peiwei Yao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

The effect of impaired thyroid-stimulating hormone (TSH) levels on fertilization rate of infertile women with endometriosis
Yazar:: Sedighe Esmaeilzadeh, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism
Yazar:: Basil Mohammed Alomair, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

A challenging case of a pituitary macroadenoma and toxic thyroid adenoma with inappropriate TSH secretion
Yazar:: Michaela Despina Carides, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy
Yazar:: Federico Hawkins Carranza, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Imaging of pancreatic tumours in mice using radiolabelled anti-Claudin4 antibodies
Yazar:: Mosley, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)